Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Molecular Pain
Published in: Molecular Pain 1/2011

Open Access 01-12-2011 | Research

Differential expression of microRNAs in mouse pain models

Authors: Ricardo Kusuda, Flaviane Cadetti, Maria I Ravanelli, Thais A Sousa, Sônia Zanon, Fernando L De Lucca, Guilherme Lucas

Published in: Molecular Pain | Issue 1/2011

Login to get access

Abstract

Background

MicroRNAs (miRNAs) are short non-coding RNAs that inhibit translation of target genes by binding to their mRNAs. The expression of numerous brain-specific miRNAs with a high degree of temporal and spatial specificity suggests that miRNAs play an important role in gene regulation in health and disease. Here we investigate the time course gene expression profile of miR-1, -16, and -206 in mouse dorsal root ganglion (DRG), and spinal cord dorsal horn under inflammatory and neuropathic pain conditions as well as following acute noxious stimulation.

Results

Quantitative real-time polymerase chain reaction analyses showed that the mature form of miR-1, -16 and -206, is expressed in DRG and the dorsal horn of the spinal cord. Moreover, CFA-induced inflammation significantly reduced miRs-1 and -16 expression in DRG whereas miR-206 was downregulated in a time dependent manner. Conversely, in the spinal dorsal horn all three miRNAs monitored were upregulated. After sciatic nerve partial ligation, miR-1 and -206 were downregulated in DRG with no change in the spinal dorsal horn. On the other hand, axotomy increases the relative expression of miR-1, -16, and 206 in a time-dependent fashion while in the dorsal horn there was a significant downregulation of miR-1. Acute noxious stimulation with capsaicin also increased the expression of miR-1 and -16 in DRG cells but, on the other hand, in the spinal dorsal horn only a high dose of capsaicin was able to downregulate miR-206 expression.

Conclusions

Our results indicate that miRNAs may participate in the regulatory mechanisms of genes associated with the pathophysiology of chronic pain as well as the nociceptive processing following acute noxious stimulation. We found substantial evidence that miRNAs are differentially regulated in DRG and the dorsal horn of the spinal cord under different pain states. Therefore, miRNA expression in the nociceptive system shows not only temporal and spatial specificity but is also stimulus-dependent.
Appendix
Available only for authorised users
Literature
1.
Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116: 281–297. 10.1016/S0092-8674(04)00045-5PubMedCrossRef
2.
He L, Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004, 5: 522–531. 10.1038/nrg1379PubMedCrossRef
3.
Kosik KS, Krichevsky AM: The Elegance of the MicroRNAs: A Neuronal Perspective. Neuron 2005, 47: 779–782. 10.1016/j.neuron.2005.08.019PubMedCrossRef
4.
Mattick JS, Makunin IV: Small regulatory RNAs in mammals. Hum Mol Genet 2005,14(1):R121–132. 10.1093/hmg/ddi101PubMedCrossRef
5.
6.
Lee RC, Feinbaum RL, Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75: 843–854. 10.1016/0092-8674(93)90529-YPubMedCrossRef
7.
Ambros V: microRNAs: tiny regulators with great potential. Cell 2001, 107: 823–826. 10.1016/S0092-8674(01)00616-XPubMedCrossRef
8.
Du T, Zamore PD: microPrimer: the biogenesis and function of microRNA. Development 2005, 132: 4645–4652. 10.1242/dev.02070PubMedCrossRef
9.
Kim VN: MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 2005, 6: 376–385. 10.1038/nrm1644PubMedCrossRef
10.
Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T: Identification of tissue-specific microRNAs from mouse. Curr Biol 2002, 12: 735–739. 10.1016/S0960-9822(02)00809-6PubMedCrossRef
11.
Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M, Greenberg ME: A brain-specific microRNA regulates dendritic spine development. Nature 2006, 439: 283–289. 10.1038/nature04367PubMedCrossRef
12.
Chen CZ, Li L, Lodish HF, Bartel DP: MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303: 83–86. 10.1126/science.1091903PubMedCrossRef
13.
Kim HK, Lee YS, Sivaprasad U, Malhotra A, Dutta A: Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol 2006, 174: 677–687. 10.1083/jcb.200603008PubMedCentralPubMedCrossRef
14.
Lee HJ, Palkovits M, Young WS: miR-7b, a microRNA up-regulated in the hypothalamus after chronic hyperosmolar stimulation, inhibits Fos translation. Proc Natl Acad Sci USA 2006, 103: 15669–15674. 10.1073/pnas.0605781103PubMedCentralPubMedCrossRef
15.
Li Y, Wang F, Lee JA, Gao FB: MicroRNA-9a ensures the precise specification of sensory organ precursors in Drosophila. Genes Dev 2006, 20: 2793–2805. 10.1101/gad.1466306PubMedCentralPubMedCrossRef
16.
Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z: The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007, 13: 486–491. 10.1038/nm1569PubMedCrossRef
17.
Lee YS, Dutta A: MicroRNAs: small but potent oncogenes or tumor suppressors. Curr Opin Investig Drugs 2006, 7: 560–564.PubMed
18.
Bai G, Ambalavanar R, Wei D, Dessem D: Downregulation of selective microRNAs in trigeminal ganglion neurons following inflammatory muscle pain. Mol Pain 2007, 3: 15–18. 10.1186/1744-8069-3-15PubMedCentralPubMedCrossRef
19.
Aldrich BT, Frakes EP, Kasuya J, Hammond DL, Kitamoto T: Changes in expression of sensory organ-specific microRNAs in rat dorsal root ganglia in association with mechanical hypersensitivity induced by spinal nerve ligation. Neuroscience 2009, 164: 711–23. 10.1016/j.neuroscience.2009.08.033PubMedCentralPubMedCrossRef
20.
Zhao J, Lee MC, Momin A, Cendan CM, Shepherd ST, Baker MD, Asante C, Bee L, Bethry A, Perkins JR, Nassar MA, Abrahamsen B, Dickenson A, Cobb BS, Merkenschlager M, Wood JN: Small RNAs control sodium channel expression, nociceptor excitability, and pain thresholds. J Neurosci 2010, 30: 10860–10871. 10.1523/JNEUROSCI.1980-10.2010PubMedCrossRef
21.
Hokfelt T, Zhang X, Wiesenfeld-Hallin Z: Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci 1994, 17: 22–30. 10.1016/0166-2236(94)90031-0PubMedCrossRef
22.
Honore P, Rogers SD, Schwei MJ, Salak-Johnson JL, Luger NM, Sabino MC, Clohisy DR, Mantyh PW: Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 2000, 98: 585–598. 10.1016/S0306-4522(00)00110-XPubMedCrossRef
23.
Honore P, Schwei J, Rogers SD, Salak-Johnson JL, Finke MP, Ramnaraine ML, Clohisy DR, Mantyh PW: Cellular and neurochemical remodeling of the spinal cord in bone cancer pain. Prog Brain Res 2000, 129: 389–397. full_textPubMedCrossRef
24.
Kim SK, Nam JW, Rhee JK, Lee WJ, Zhang BT: miTarget: microRNA target gene prediction using a support vector machine. BMC Bioinformatics 2006, 7: 411. 10.1186/1471-2105-7-411PubMedCentralPubMedCrossRef
25.
Rodriguez Parkitna J, Korostynski M, Kaminska-Chowaniec D, Obara I, Mika J, Przewlocka B, Przewlocki R: Comparison of gene expression profiles in neuropathic and inflammatory pain. J Physiol Pharmacol 2006, 57: 401–414.PubMed
26.
27.
Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N: Combinatorial microRNA target predictions. Nat Genet 2005, 37: 495–500. 10.1038/ng1536PubMedCrossRef
28.
Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB: Prediction of mammalian microRNA targets. Cell 2003, 115: 787–798. 10.1016/S0092-8674(03)01018-3PubMedCrossRef
29.
Zimmermann M: Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16: 109–110. 10.1016/0304-3959(83)90201-4PubMedCrossRef
30.
Seltzer Z, Dubner R, Shir Y: A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 1990, 43: 205–218. 10.1016/0304-3959(90)91074-SPubMedCrossRef
31.
Dixon WJ: Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980, 20: 441–462. 10.1146/annurev.pa.20.040180.002301PubMedCrossRef
32.
Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53: 55–63. 10.1016/0165-0270(94)90144-9PubMedCrossRef
33.
Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25: 402–408. 10.1006/meth.2001.1262PubMedCrossRef
34.
Alvares D, Fitzgerald M: Building blocks of pain: the regulation of key molecules in spinal sensory neurones during development and following peripheral axotomy. Pain 1999,6(Suppl):S71–85. 10.1016/S0304-3959(99)00140-2PubMedCrossRef
35.
Woolf CJ: Phenotypic modification of primary sensory neurons: the role of nerve growth factor in the production of persistent pain. Philos Trans R Soc Lond B Biol Sci 1996, 351: 441–448. 10.1098/rstb.1996.0040PubMedCrossRef
36.
Mannion RJ, Costigan M, Decosterd I, Amaya F, Ma QP, Holstege JC, Ji RR, Acheson A, Lindsay RM, Wilkinson GA, Woolf CJ: Neurotrophins: peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity. Proc Natl Acad Sci USA 1999, 96: 9385–9390. 10.1073/pnas.96.16.9385PubMedCentralPubMedCrossRef
37.
Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R: MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 2005, 7: 719–723. 10.1038/ncb1274PubMedCentralPubMedCrossRef
38.
Fabian MR, Sonenberg N, Filipowicz W: Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010, 79: 351–379. 10.1146/annurev-biochem-060308-103103PubMedCrossRef
39.
Herranz H, Cohen SM: MicroRNAs and gene regulatory networks: managing the impact of noise in biological systems. Genes Dev 2010, 24: 1339–1344. 10.1101/gad.1937010PubMedCentralPubMedCrossRef
40.
41.
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D: The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389: 816–824. 10.1038/39807PubMedCrossRef
42.
Barth AL: Visualizing circuits and systems using transgenic reporters of neural activity. Curr Opin Neurobiol 2007, 17: 567–571. 10.1016/j.conb.2007.10.003PubMedCentralPubMedCrossRef
43.
Kovacs KJ: Measurement of immediate-early gene activation-c-fos and beyond. J Neuroendocrinol 2008, 20: 665–672. 10.1111/j.1365-2826.2008.01734.xPubMedCrossRef
44.
Sng JC, Taniura H, Yoneda Y: A tale of early response genes. Biol Pharm Bull 2004, 27: 606–612. 10.1248/bpb.27.606PubMedCrossRef
45.
Coggeshall RE: Fos, nociception and the dorsal horn. Prog Neurobiol 2005, 77: 299–352.PubMed
46.
Lima D, Almeida A: The medullary dorsal reticular nucleus as a pronociceptive centre of the pain control system. Prog Neurobiol 2002, 66: 81–108. 10.1016/S0301-0082(01)00025-9PubMedCrossRef
47.
Zhao ZQ: Neural mechanism underlying acupuncture analgesia. Prog Neurobiol 2008, 85: 355–375. 10.1016/j.pneurobio.2008.05.004PubMedCrossRef
48.
Herdegen T, Zimmermann M: Immediate early genes (IEGs) encoding for inducible transcription factors (ITFs) and neuropeptides in the nervous system: functional network for long-term plasticity and pain. Prog Brain Res 1995, 104: 299–321. full_textPubMedCrossRef
49.
50.
Harris JA: Using c-fos as a neural marker of pain. Brain Res Bull 1998, 45: 1–8. 10.1016/S0361-9230(97)00277-3PubMedCrossRef
51.
Zimmermann M: Immediate-early genes in the nervous system-are they involved in mechanisms of chronic pain? Patol Fiziol Eksp Ter 1992, 4: 47–51.PubMed
52.
Kerr BJ, Bradbury EJ, Bennett DL, Trivedi PM, Dassan P, French J, Shelton DB, McMahon SB, Thompson SW: Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord. J Neurosci 1999, 19: 5138–5148.PubMed
53.
Merighi A, Salio C, Ghirri A, Lossi L, Ferrini F, Betelli C, Bardoni R: BDNF as a pain modulator. Prog Neurobiol 2008, 85: 297–317. 10.1016/j.pneurobio.2008.04.004PubMedCrossRef
54.
Thompson SW, Bennett DL, Kerr BJ, Bradbury EJ, McMahon SB: Brain-derived neurotrophic factor is an endogenous modulator of nociceptive responses in the spinal cord. Proc Natl Acad Sci USA 1999, 96: 7714–7718. 10.1073/pnas.96.14.7714PubMedCentralPubMedCrossRef
55.
Galan A, Lopez-Garcia JA, Cervero F, Laird JM: Activation of spinal extracellular signaling-regulated kinase-1 and -2 by intraplantar carrageenan in rodents. Neurosci Lett 2002, 322: 37–40. 10.1016/S0304-3940(02)00078-2PubMedCrossRef
56.
Wei F, Qiu CS, Kim SJ, Muglia L, Maas JW, Pineda VV, Xu HM, Chen ZF, Storm DR, Muglia LJ, Zhuo M: Genetic elimination of behavioral sensitization in mice lacking calmodulin-stimulated adenylyl cyclases. Neuron 2002, 36: 713–726. 10.1016/S0896-6273(02)01019-XPubMedCrossRef
57.
Zeitz KP, Giese KP, Silva AJ, Basbaum AI: The contribution of autophosphorylated alpha-calcium-calmodulin kinase II to injury-induced persistent pain. Neuroscience 2004, 128: 889–898. 10.1016/j.neuroscience.2004.07.029PubMedCrossRef
58.
Davar G, Shalish C, Blumenfeld A, Breakfield XO: Exclusion of p75NGFR and other candidate genes in a family with hereditary sensory neuropathy type II. Pain 1996, 67: 135–139. 10.1016/0304-3959(96)03113-2PubMedCrossRef
59.
Fukui Y, Ohtori S, Yamashita M, Yamauchi K, Inoue G, Suzuki M, Orita S, Eguchi Y, Ochiai N, Kishida S, Takaso M, Wakai K, Hayashi Y, Aoki Y, Takahashi K: Low affinity NGF receptor (p75 neurotrophin receptor) inhibitory antibody reduces pain behavior and CGRP expression in DRG in the mouse sciatic nerve crush model. J Orthop Res 2009, 28: 279–283.
60.
Watanabe T, Ito T, Inoue G, Ohtori S, Kitajo K, Doya H, Takahashi K, Yamashita T: The p75 receptor is associated with inflammatory thermal hypersensitivity. J Neurosci Res 2008, 86: 3566–3574. 10.1002/jnr.21808PubMedCrossRef
61.
Hasegawa S, Kohro Y, Shiratori M, Ishii S, Shimizu T, Tsuda M, Inoue K: Role of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic pain. PLoS One 2010, 5: e10467. 10.1371/journal.pone.0010467PubMedCentralPubMedCrossRef
62.
Inoue M, Ma L, Aoki J, Ueda H: Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain. J Neurochem 2008, 107: 1556–1565. 10.1111/j.1471-4159.2008.05725.xPubMedCrossRef
63.
Yeo JF, Ong WY, Ling SF, Farooqui AA: Intracerebroventricular injection of phospholipases A2 inhibitors modulates allodynia after facial carrageenan injection in mice. Pain 2004, 112: 148–155. 10.1016/j.pain.2004.08.009PubMedCrossRef
64.
Contreras PC, Vaught JL, Gruner JA, Brosnan C, Steffler C, Arezzo JC, Lewis ME, Kessler JA, Apfel SC: Insulin-like growth factor-I prevents development of a vincristine neuropathy in mice. Brain Res 1997, 774: 20–26. 10.1016/S0006-8993(97)81682-4PubMedCrossRef
65.
de Pablo F, Banner LR, Patterson PH: IGF-I expression is decreased in LIF-deficient mice after peripheral nerve injury. Neuroreport 2000, 11: 1365–1368. 10.1097/00001756-200004270-00043PubMedCrossRef
66.
Staaf S, Oerther S, Lucas G, Mattsson JP, Ernfors P: Differential regulation of TRP channels in a rat model of neuropathic pain. Pain 2009, 144: 187–199. 10.1016/j.pain.2009.04.013PubMedCrossRef
67.
Gaveriaux-Ruff C, Karchewski LA, Hever X, Matifas A, Kieffer BL: Inflammatory pain is enhanced in delta opioid receptor-knockout mice. Eur J Neurosci 2008, 27: 2558–2567. 10.1111/j.1460-9568.2008.06223.xPubMedCentralPubMedCrossRef
68.
Nadal X, Banos JE, Kieffer BL, Maldonado R: Neuropathic pain is enhanced in delta-opioid receptor knockout mice. Eur J Neurosci 2006, 23: 830–834. 10.1111/j.1460-9568.2006.04569.xPubMedCrossRef
Metadata
Title
Differential expression of microRNAs in mouse pain models
Authors
Ricardo Kusuda
Flaviane Cadetti
Maria I Ravanelli
Thais A Sousa
Sônia Zanon
Fernando L De Lucca
Guilherme Lucas
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Molecular Pain / Issue 1/2011
Electronic ISSN: 1744-8069
DOI
https://doi.org/10.1186/1744-8069-7-17

Other articles of this Issue 1/2011

Molecular Pain 1/2011 Go to the issue

Research

Behavioral evidence for the differential regulation of p-p38 MAPK and p-NF-κB in rats with trigeminal neuropathic pain

Research

Preserved acute pain and impaired neuropathic pain in mice lacking protein interacting with C Kinase 1

Research

Highly localized interactions between sensory neurons and sprouting sympathetic fibers observed in a transgenic tyrosine hydroxylase reporter mouse

Research

Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice

Research

A local anesthetic, ropivacaine, suppresses activated microglia via a nerve growth factor-dependent mechanism and astrocytes via a nerve growth factor-independent mechanism in neuropathic pain

Research

The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system